-
NEUROLOGIST & NEUROCRITICAL CARE
Paul Vespa, MD
UCLA, Los Angeles, CA
“Ceribell, [is] easy to use, easy to apply, and would be greatly utilized in emergency departments or small hospitals where they just don’t have the available services to rapidly assess the patient.”
-
ED PHYSICIAN
Laleh Gharahbaghian, MD
Stanford Health Care, Palo Alto, CA
“They are eager to use it [Ceribell] because they understand its effect and impact and the data that they can obtain from it quite easily and quite quickly and quite accurately.”
-
NURSE
Mary Kay Bader, CCRN, CNRN
Mission Hospital, Mission Viejo, CA
“The Ceribell EEG technologies have improved our ability to detect and treat seizures… it’s readily available, it’s in the ICU, it’s in the emergency department.”
-
NEUROLOGIST
Margo Block, DO
University of Kansas Medical Center, Kansas City, KS
“It’s just made a huge difference as far as the timing and being able to rapidly assess and treat appropriately and to really triage the brain in a way that we have never been able to prior to this technology [Ceribell].”
-
NURSE
Daiwai Olson, PhD
UT Southwestern, Dallas, TX
“Instead of intubating the patient, sending them to the ICU, expending those efforts, this patient never saw the neuro ICU. They were discharged home.”
-
NEUROLOGIST
Parshaw Dorriz, MD
Mission Hospital, Mission Viejo, CA
“[Ceribell] has changed our culture as far as how we manage patients with seizures, how we manage patients neurologically, and doing it in a way that doesn’t compromise patient care.”
Non-convulsive seizures are prevalent in critically ill patients1
Time in seizure is associated with increase in mortality6
Ceribell Point-of-Care EEG
What Sets Ceribell Apart
Resources
Fox Business News: Doctors using AI-driven devices to help detect seizure activity in patients
Read MoreIn The News
Ceribell Announces Publication of Study Demonstrating Significant Reduction in Length of ICU Stays and Better Patient Outcomes with Ceribell Point-of-Care EEG Compared to Conventional EEG
Read MorePress Release
Litigation Page
References and Citations
1. Herman, S.T., et al. (2015) J Clin Neurophysiol. 32(2):87-95
2. Laccheo, I., et al. (2015) Neurocrit Care. 22:202-211
3. De Marchis, G.M., et al. (2016) Neurology. 86(3):253-260
4. Claassen, J., et al. (2004). Neurology. 62(10):1743-1748
5. Rudin, D., et al. (2011) Epilepsy Res. 96(1-2):140-150
6. Young, G.B., et al. (1996). Neurology, 47(1):83-89
7. Puranik, T., et al., (2025) Neurocritical Care Society Annual Meeting Poster
8. Ceribell, Inc., (2025, April 30) [Press release]
9. CMS FY 2024 IPPS Final Rule. CMS-1785-F, 88 Fed. Reg. 58927-58930, Aug. 28, 2023
10. Desai, M., et al. (2025) Neurocrit Care. 42(1):108-117
11. Eberhard, E., et al. (2023) J Neurosci Nurs.
12. Madill, E.S., et al. (2022) Epileptic Disorders. 24(3):507-516
13. Ward, J., et al. (2023) Front. Digit. Health. 5(1)
* for detecting status epilepticus
** As of Oct 2025